CAR-T Cell Therapy Targeting Surface Expression of TYRP1 to Treat Cutaneous and Rare Melanoma Subtypes

Investigators identified Tyrosinase Related Protein 1 as a CAR-T cell therapy target to treat patients with cutaneous and rare melanoma subtypes unresponsive to immune checkpoint blockade.